These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35290067)

  • 1. Liposome-Encapsulated Tiancimycin A Is Active against Melanoma and Metastatic Breast Tumors: The Effect of cRGD Modification of the Liposomal Carrier and Tiancimycin A Dose on Drug Activity and Toxicity.
    Feng X; Liu H; Pan J; Xiong Y; Zhu X; Yan X; Duan Y; Huang Y
    Mol Pharm; 2022 Apr; 19(4):1078-1090. PubMed ID: 35290067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HER2 Immunoliposomes: Antitumor Efficacy Attributable to Targeted Delivery of Anthraquinone-Fused Enediyne.
    Feng X; Wen Z; Zhu X; Yan X; Duan Y; Huang Y
    Adv Sci (Weinh); 2024 May; 11(17):e2307865. PubMed ID: 38355309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
    Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
    Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramolecular C-C Bond Formation Links Anthraquinone and Enediyne Scaffolds in Tiancimycin Biosynthesis.
    Gui C; Kalkreuter E; Liu YC; Adhikari A; Teijaro CN; Yang D; Chang C; Shen B
    J Am Chem Soc; 2022 Nov; 144(44):20452-20462. PubMed ID: 36279548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptomycin-induced ribosome engineering complemented with fermentation optimization for enhanced production of 10-membered enediynes tiancimycin-A and tiancimycin-D.
    Zhuang Z; Jiang C; Zhang F; Huang R; Yi L; Huang Y; Yan X; Duan Y; Zhu X
    Biotechnol Bioeng; 2019 Jun; 116(6):1304-1314. PubMed ID: 30712262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to Enediyne Antitumor Antibiotics by Sequestration.
    Chang CY; Yan X; Crnovcic I; Annaval T; Chang C; Nocek B; Rudolf JD; Yang D; Hindra ; Babnigg G; Joachimiak A; Phillips GN; Shen B
    Cell Chem Biol; 2018 Sep; 25(9):1075-1085.e4. PubMed ID: 29937405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation.
    Yu KF; Zhang WQ; Luo LM; Song P; Li D; Du R; Ren W; Huang D; Lu WL; Zhang X; Zhang Q
    Int J Nanomedicine; 2013; 8():2473-85. PubMed ID: 23885174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin α
    Fu S; Zhao Y; Sun J; Yang T; Zhi D; Zhang E; Zhong F; Zhen Y; Zhang S; Zhang S
    Colloids Surf B Biointerfaces; 2021 May; 201():111623. PubMed ID: 33636597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles.
    Fang Y; Jiang Y; Zou Y; Meng F; Zhang J; Deng C; Sun H; Zhong Z
    Acta Biomater; 2017 Mar; 50():396-406. PubMed ID: 28065871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maleimide-Functionalized Liposomes: Prolonged Retention and Enhanced Efficacy of Doxorubicin in Breast Cancer with Low Systemic Toxicity.
    Tang C; Yin D; Liu T; Gou R; Fu J; Tang Q; Wang Y; Zou L; Li H
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects.
    Song Z; Lin Y; Zhang X; Feng C; Lu Y; Gao Y; Dong C
    Int J Nanomedicine; 2017; 12():1941-1958. PubMed ID: 28331317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmentally Self-Adaptative Nanocarriers Suppress Glioma Proliferation and Stemness via Codelivery of shCD163 and Doxorubicin.
    Liu J; Zhang Y; Chen T; Chen H; He H; Jin T; Wang J; Ke Y
    ACS Appl Mater Interfaces; 2020 Nov; 12(47):52354-52369. PubMed ID: 33196179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome shuffling based on different types of ribosome engineering mutants for enhanced production of 10-membered enediyne tiancimycin-A.
    Liu H; Jiang C; Lin J; Zhuang Z; Kong W; Liu L; Huang Y; Duan Y; Zhu X
    Appl Microbiol Biotechnol; 2020 May; 104(10):4359-4369. PubMed ID: 32236679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 Hydroxylase TnmL Catalyzing Sequential Hydroxylation with an Additional Proofreading Activity in Tiancimycin Biosynthesis.
    Annaval T; Teijaro CN; Adhikari A; Yan X; Chen JJ; Crnovcic I; Yang D; Shen B
    ACS Chem Biol; 2021 Jul; 16(7):1172-1178. PubMed ID: 34138533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental anticancer therapy with vascular-disruptive peptide and liposome-entrapped chemotherapeutic agent.
    Sochanik A; Mitrus I; Smolarczyk R; Cichoń T; Snietura M; Czaja M; Szala S
    Arch Immunol Ther Exp (Warsz); 2010 Jun; 58(3):235-45. PubMed ID: 20383751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. αvβ3 integrin-specific exosomes engineered with cyclopeptide for targeted delivery of triptolide against malignant melanoma.
    Gu Y; Du Y; Jiang L; Tang X; Li A; Zhao Y; Lang Y; Liu X; Liu J
    J Nanobiotechnology; 2022 Aug; 20(1):384. PubMed ID: 35999612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic RGD-Decorated Liposomal Gossypol AT-101 Targeting for Enhanced Antitumor Effect.
    Liu H; Zhang R; Zhang D; Zhang C; Zhang Z; Fu X; Luo Y; Chen S; Wu A; Zeng W; Qu K; Zhang H; Wang S; Shi H
    Int J Nanomedicine; 2022; 17():227-244. PubMed ID: 35068931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic RGD-Functionalized and Disulfide-Crosslinked Iodine-Rich Polymersomes as a Robust and Smart Theranostic Agent for Targeted CT Imaging and Chemotherapy of Tumor.
    Zou Y; Wei Y; Sun Y; Bao J; Yao F; Li Z; Meng F; Hu C; Storm G; Zhong Z
    Theranostics; 2019; 9(26):8061-8072. PubMed ID: 31754381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zwitterionic nanoparticles constructed from bioreducible RAFT-ROP double head agent for shell shedding triggered intracellular drug delivery.
    Huang P; Liu J; Wang W; Zhang Y; Zhao F; Kong D; Liu J; Dong A
    Acta Biomater; 2016 Aug; 40():263-272. PubMed ID: 26607767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α
    Zhong P; Gu X; Cheng R; Deng C; Meng F; Zhong Z
    Int J Nanomedicine; 2017; 12():7913-7921. PubMed ID: 29138558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.